Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease and Addressing Exacerbation and Lung Function
Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease and Addressing Exacerbation and Lung Function
The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosis
Novel B-Cell Depleting Targeted Therapies to Improve Outcomes in Patients With Sjögren’s Disease
Novel B-Cell Depleting Targeted Therapies to Improve Outcomes in Patients With Sjögren’s Disease
Re Engineering B Cell Signaling in Sjögren’s Disease: BAFF/APRIL Blockade as a New Path to Durable Disease Control
Does nasal etripamil for PSVT drop blood pressure?
Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists
Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists
Update from AHA2025: New Data on Disease Modifying Therapy in the Management of ATTR Amyloidosis
Patient Self-Management of Acute PSVT: A Systematic Review of Etripamil Data from AHA25
Update on Non-Statin Lipid-Lowering Therapies from ESC 2025
Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering, as Presented at ESC 2025
Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering, as Presented at ESC 2025
The Potential for Targeted Inhibition of Factor XI/XIa to Provide Safe and Effective Protection from a Secondary Ischemic Noncardioembolic Stroke
Therapeutic Update on COPD with Type 2 Inflammation
Therapeutic Update on COPD with Type 2 Inflammation
Is There a Safe and Effective Anticoagulation Strategy for Secondary Prevention of Non-Cardioembolic Ischemic Stroke?
Non-Statin Cholesterol Management Update
LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”